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Introduction: Mortality from dengue infection is mostly due to shock. Among dengue patients with shock,
approximately 30% have recurrent shock that requires a treatment change. Here, we report development of a
clinical rule for use during a patient’s first shock episode to predict a recurrent shock episode.
Methods: The study was conducted in Center for Preventive Medicine in Vinh Long province and the Children’s
Hospital No. 2 in Ho Chi Minh City, Vietnam. We included 444 dengue patients with shock, 126 of whom had
recurrent shock (28%). Univariate and multivariate analyses and a preprocessing method were used to evaluate and
select 14 clinical and laboratory signs recorded at shock onset. Five variables (admission day, purpura/ecchymosis,
ascites/pleural effusion, blood platelet count and pulse pressure) were finally trained and validated by a 10-fold val-
idation strategy with 10 times of repetition, using a logistic regression model.
Results: The results showed that shorter admission day (fewer days prior to admission), purpura/ecchymosis,
ascites/pleural effusion, low platelet count and narrow pulse pressure were independently associated with recurrent
shock. Our logistic prediction model was capable of predicting recurrent shock when compared to the null method
(P < 0.05) and was not outperformed by other prediction models. Our final scoring rule provided relatively good
accuracy (AUC, 0.73; sensitivity and specificity, 68%). Score points derived from the logistic prediction model
revealed identical accuracy with AUCs at 0.73. Using a cutoff value greater than −154.5, our simple scoring rule
showed a sensitivity of 68.3% and a specificity of 68.2%.
Conclusions: Our simple clinical rule is not to replace clinical judgment, but to help clinicians predict recurrent
shock during a patient’s first dengue shock episode.Introduction
Dengue virus infection has become an important global
problem. It is quickly spreading to South America and
Africa [1]. It is estimated that 20,000 patients die from this
disease each year from among the 2.5 billion people who
are at risk for dengue in over 100 countries [2]. The
pathogenesis of dengue infection is not completely under-
stood. Several mechanisms have been proposed, including
a virulence factor [3-5], secondary infection [5], host gen-
etic factors [6,7], host immune response [8-10], memory
T-cell-mediated pathogenesis [8], suppressed Th1 and/or* Correspondence: hiraken@nagasaki-u.ac.jp
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reproduction in any medium, provided the orpredominant Th2 responses [9], cytokine tsunami [10],
anti-nonstructural 1 protein antibodies that cross-react
with vascular endothelium [11] and host physiological
factors [12].
Dengue disease, as defined according to the 1997
World Health Organization (WHO) classifications,
ranges from asymptomatic or dengue fever to severe
dengue hemorrhagic fever and dengue shock syndrome
(DSS) [13]. Recently, in the 2009 revised dengue classifi-
cation system proposed by Dengue Control, the WHO
has added a classification of the severity of the disease
according to the presence of dengue warning signs [14].
To date, there is no approved vaccine or antiviral drug
to treat for this disease. Vector control, early appropriate
treatment and educational programs are currently the
only ways to reduce mortality and the global disease. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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early appropriate treatment [18]. Death due to dengue
infection is reportedly 50 times higher in dengue pa-
tients with shock than in those without shock [19].
Among shock patients, approximately 30% have recur-
rent shock that reportedly affects the therapy protocol
[20]. To the best of our knowledge, however, no previous
report has described a tool for prediction of patients
who will develop a second dengue shock episode. In this
study, we developed a model to predict, at the time of




The current study was performed at the Center for Pre-
ventive Medicine in Vinh Long province and the Chil-
dren’s Hospital No. 2 in Ho Chi Minh City, Vietnam.
The study design was a prospective cohort analysis of
the clinical signs and laboratory test values of children
(ages 6 months to 15 years) that were recorded around
the time of the first shock episode. The entry criteria
were suspected clinical dengue infection with proven
dengue virus on the basis of laboratory evidence and
hypovolemic shock that occurred between January 2002
and December 2007. Proven dengue virus infection was
diagnosed if the virus was isolated, if RNA was detected
by real-time PCR assay or if the serological assay was
positive, as fully described in our previous publications
[7,21,22]. DSS was classified according to the WHO
1997 classification criteria [13] without fulfilling theTable 1 Clinical characteristics, laboratory parameters and un
Characteristics Single shock Recu
(N = 318) (N =
Age (years) 10 (0.25 to 15)b 10 (0
Females/total 171/318 73/1
Admission day 3.97 ± 1.20c 3.71
Days of shock 4.95 ± 1.34 4.67
Petechia 144/318 (45%) 61/1
Tourniquet test 12/318 (4%) 5/12
Nose/gum bleeding 40/318 (13%) 21/1
Purpura/ecchymosis 98/318 (31%) 62/1
GI bleeding 36/318 (11%) 23/1
Ascites/pleural effusion 114/318 (36%) 92/1
HCT (%) 43.01 ± 5.83 43.5
PLTs (×103/μl) 110.59 ± 56.10 96.6
WBC count (×103/μl) 5.55 ± 3.75 4.98
Pulse pressure (mmHg) 18.41 ± 6.26 16.3
aDays of shock, number of illness days prior to the first shock; GI, gastrointestinal; H
days prior to admission and day 1 of illness were assigned as the day of fever onse
for continuous variables not normally distributed. cMean ± SD calculated using Studcriterion for presence of thrombocytopenia [23]. Exclu-
sion criteria were the presence of chronic illness or
massive bleeding that required blood transfusion.
Around the time of shock, the relevant patient history
regarding clinical symptoms and signs, as well as the la-
boratory parameters listed in Table 1, were recorded.
These variables are widely used in our hospitals for the
diagnosis and monitoring of dengue shock patients.
Pleural effusion and ascites were detected by chest X-ray
and ultrasound. A patient was defined as having devel-
oped recurrent shock if he or she had received adequate
fluid according to the WHO 1997 guidelines for volume
replacement [13] and had tachycardia, abnormal cool-
ness of limbs and a pulse pressure ≤25 mmHg that had
previously reached a level ≥30 mmHg [20].
The minimal required sample size was determined by
rule of thumb, in which at least ten patients per group
were required for each included predictive variable
[24,25]. We aimed to use less than ten variables to build
prediction models for ease of use in clinical practice.
The required sample size was at least 100 participants
per group. This study was approved by the institutional
ethical review committees of the Institute of Tropical
Medicine, Nagasaki University, and the Pasteur Institute
in Ho Chi Minh City. Written informed consent from all
participants’ parents or guardians was required upon
enrollment.
Univariate and multivariate analyses
The primary outcome variable was recurrent shock diag-
nosis at the time of hospital discharge. Univariateivariate analysisa
rrent shock Missing data (%) P-value
126)
.5 to 15) 0 0.95
26 0 0.43
± 1.08 1 (0.2) 0.035
± 1.38 14 (3.2) 0.054
26 (48%) 0 0.55
6 (4%) 2 (0.5) 0.93
26 (17%) 0 0.26
26 (49%) 0 <0.001
26 (18%) 0 0.052
26 (73%) 1 (0.2) <0.001
0 ± 5.50 3 (0.7) 0.43
3 ± 60.34 16 (3.6) 0.024
± 2.73 44 (9.9) 0.141
1 ± 7.24 0 0.001
CT, hematocrit; PLTs, platelets; WBC, white blood cell. Admission day, fever
t. bMedian (minimum, maximum) calculated using the Mann–Whitney U test
ent’s t-test for continuous variables normally distributed.
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(SPSS, Inc, Chicago, IL, USA). Measures of skewness
and kurtosis were used to test the normal distribution of
continuous variables. Student’s t-test was used for con-
tinuous variables normally distributed, and the Mann–
Whitney U test was used for continuous variables that
were not normally distributed. χ2 analysis was used for
categorical variables. A difference with a P value <0.05
was considered significant. Multivariate logistic regression
analysis was used to find the independent predictors of re-
current shock using MedCalc version 11.0 statistical soft-
ware (MedCalc Software, Ostend, Belgium).
Missing data analysis
Missing data ranged from 0% to 9.9%. Little’s missing
completely at random test [26] was performed using
SPSS software version 16.0, which showed a nonsignifi-
cant result (P > 0.10), suggesting that the data were miss-
ing completely at random. Therefore, multiple imputation
algorithms were used to analyze the missing data using
NORM software version 2.03 [27]. The multiple logistic
regression model was employed to input missing data.
Preprocessing variable selection
To increase the performance of the prediction model
[28], a preprocessing method was employed to reduce
the number of variables using Weka 3.7.7 software [29].
We used the assessment method in WrapperSubsetEval
[30] combined with the best first search method in the
forward direction [31] and the learning scheme of our
logistic regression prediction model (Logistic). A ten-
fold cross-validation method was used with the number
of folds set at five and the seed set at one.
Training and validation of the prediction model
Because a simpler rule would be preferred by clinicians,
particularly in remote areas, we built a simple traditional
rule using a logistic regression model [32]. Logistic was
built and compared to ZeroR, a baseline model without
predictive power, to identify the predictive power of the
Logistic model. The overall performance of the data-
mining model was assessed by calculation of the area
under the curve (AUC) from the receiver operating
characteristic (ROC) curve [33]. Weka 3.7.7 software
[29] was used to train and validate all models in a ten-
fold validation strategy with ten rounds of ten repetitions
as previously described [34,35]. Briefly, the whole data set
was randomly split into ten equal subsets (Figure 1). For
ten times, nine subsets were used to train the model and
the remaining subset was used to validate the AUC of
each model. The cross-validation was repeated 10 times
to yield a total of 100 AUC values for each model. The
overall accuracy of these models, represented by the mean
and standard deviation of 100 AUC values, was comparedusing the corrected, resampled t-test [36]. Differences be-
tween models with P values <0.05 were considered
significant.
Initially, we used the default settings of the Weka
software to build the prediction model. Next, we opti-
mized parameters to calculate the highest AUC value.
The full description of parameter-setting is presented
in Additional file 1.
Score points were derived by multiplying and rounding
regression coefficients to calculate the lowest integer,
then simplifying them to achieve a scoring system. The
optimal cutoff value was chosen as the q value of the
ROC curve, at which sensitivity equals specificity.Comparison of logistic regression prediction model with
the other ten prediction models
Ten binary prediction models (artificial neural network
(ANN), k-nearest neighbors algorithm (kNN), C4.5 decision
tree (J48), LogitBoost classification algorithm (LgBoost), lo-
gistic regression tree (LRT), naïve Bayes classifier (NaiveB),
random forests (RF), random subspace (RSSpace), sequen-
tial minimal optimization (SMO) for support vector ma-
chines and a combination of ANN, LgBoost and RSSpace
(Vote)) were built as described above. The overall accuracy
of these rules was compared using the mean and standard
deviation of 100 AUC values per model by using the cor-
rected, resampled t-test [36].Results
Patient characteristics and univariate analysis
A total of 444 proven dengue patients with shock, in-
cluding 318 patients (72%) with a single shock episode
and 126 (28%) with recurrent shock, were enrolled
(Table 1). No deaths were recorded in the study. There
were no significant differences in age and gender be-
tween the control (single shock) and recurrent shock
DSS groups. The mean admission day (mean number of
illness days prior to admission, and day 1 of illness was
assigned as the day of fever onset) for the recurrent
shock group was significantly lower than that of the sin-
gle shock group (P < 0.05). The mean of the day of shock
(illness days prior to the first shock) was slightly lower
in the recurrent shock group than in the single shock
group (P = 0.054). For the clinical and laboratory param-
eters, purpura/ecchymosis (P < 0.001), ascites/pleural ef-
fusion (P < 0.001) and lower platelet count (P < 0.05) and
narrow pulse pressure (P < 0.001) were found more com-
monly in the recurrent shock group than in the single
shock group. Gastrointestinal bleeding was closely asso-
ciated with recurrent shock (P = 0.052). No significant
differences between the two groups were found for pe-
techia, tourniquet test, nose/gum bleeding, hematocrit
and white blood cell count.
Figure 1 Flowchart of the development of models for prediction of recurrent shock during a patient’s first dengue shock episode.
PLT, platelet.
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rule
Because the clinical rule should be reliable and easy to
apply [32], we aimed to develop a simple rule to predict
the recurrent shock patients using the logistic regression
model. After the preprocessing method of variables re-
duction, nine variables, including age, admission day,
day of shock, petechia, purpura/ecchymosis, gastrointes-
tinal bleeding, ascites/pleural effusion, platelet count,
and pulse pressure, remained and were analyzed using a
multivariate logistic regression model. The results in
Table 2 show that admission day, purpura/ecchymosis,
ascites/pleural effusion, blood platelet count, and pulse
pressure, independently correlated with recurrent shock
in a multivariate model (P < 0.05).
Five variables (admission day, purpura/ecchymosis, as-
cites/pleural effusion, blood platelet count and pulse
pressure) were further trained and validated using a ten-
fold validation strategy with ten rounds of repetition
[34,35] using Weka 3.7.7 software [29]. Next, scores
were derived by multiplying and rounding regression co-
efficients to calculate the lowest integer, then simplifying
the coefficients to achieve a scoring system (Table 3).
The total score for patients in the whole data set ranged
from −406 points to +53 points. Figure 2 shows the per-
formance of the logistic models built by using the equa-
tion and the scoring systems, revealing identical accuracy
with AUCs at 0.73 when the whole data set was applied.
Using a cutoff value greater than −154.5, the simple point
rule revealed a sensitivity of 68.3% and a specificity of
68.2%.
Comparison of 11 prediction models
In this study, 11 popular data-mining methods (ANN,
kNN, J48, LgBoost, LRT, Logistic, NaiveB, RF, RSSpace,
SMO and Vote) were trained and compared to the base-
line ZeroR model to identify the predictability power ofTable 2 Multivariate logistic regression model used to predic
Predictors OR (95% CI)
Age 1.01 (0.95 to 1.08)
Admission dayb,c 0.82 (0.69 to 0.99)
Day of shock 0.91 (0.77 to 1.07)
Petechia 1.13 (0.75 to 1.71)
Purpura/ecchymosisc 2.17 (1.43 to 3.32)
GI bleeding 1.75 (0.99 to 3.09)
Ascites/pleural effusionc 0.23 (0.14 to 0.42)
PLT (×103/μl)c,d 0.99 (0.99 to 0.99)
Pulse pressure (mmHg)c,d 0.96 (0.93 to 0.98)
aCI, confidence interval; GI, gastrointestinal; OR, odds ratio; PLT, platelet. Dengue sho
dengue fever.
bOR represents the decremental odds of recurrent shock for every unit decrease of
rules. dOR represents the incremental odds of recurrent shock for every unit increasthe built models. Five variables (admission day, purpura/
ecchymosis, ascites/pleural effusion, blood platelet count
and pulse pressure) were computed using a ten-fold val-
idation strategy. The results showed that all 11 predic-
tion models possessed AUC values between 0.645 and
0.730 (Additional file 2). Compared to the baseline
ZeroR method, the 11 prediction models all showed
an ability to predict recurrent shock (P < 0.05). Among
these models, the Vote model demonstrated the highest
AUC at 0.730, followed by LgBoost (0.720), NaiveB
(0.705), Logistic (0.703), LRT (0.703), kNN (0.696), SMO
(0.695), ANN (0.695), RF (0.694), RSSpace (0.694) and
J48 (0.645). Compared with the other four best models
(Vote, LgBoost, NaiveB and Logistic), the J48 model was
significantly outperformed in overall accuracy.
Discussion
Medical doctors often initiate fluid resuscitation by using
normal saline solution or Ringer’s lactate solution. Most
children with DSS recover from shock with this treat-
ment regimen; however, 28% to 30% have recurrent
shock that requires administration of colloidal solutions
and more intensive care [20] (Table 1). Therefore, a clin-
ical decision rule is needed to predict recurrent shock
during a patient’s first dengue shock episode. In this
study, we defined a simple, practical, relatively accurate
clinical decision rule (sensitivity and specificity of 68%)
that can be applied at the bedside [32] to predict recur-
rent shock in children hospitalized for a first dengue
shock episode. The rule contains a list of items with a
detailed scoring system and does not require compli-
cated mathematical computation.
Our univariate analysis revealed many factors associ-
ated with recurrent shock. There were more signs of
purpura/ecchymosis, gastrointestinal bleeding, ascites/
pleural effusion, low platelet count and narrow pulse
pressure in recurrent shock patients compared witht dengue shock syndrome and nonshock casesa
Adjusted OR (95% CI) P-value
1.05 (0.98 to 1.13) 0.1756
0.66 (0.52 to 0.83) 0.0041
0.91 (0.76 to 1.08) 0.3476
0.78 (0.46 to 1.30) 0.3381
1.78 (1.11 to 2.86) 0.017
1.37 (0.73 to 2.58) 0.1290
0.24 (0.13 to 0.43) 0.0001
0.99 (0.99 to 0.99) 0.0148
0.96 (0.93 to 0.99) 0.0163
ck syndrome refers to dengue hemorrhagic fever, and nonshock cases refers to
one day in admission days. cVariables were selected for developing the clinical
e of 1,000 platelets per microliter or every 1 mmHg increase in pulse pressure.
Table 3 Assigning score values for clinical decision rulea
Variables Pointsb
Admission day −40 for each day
Purpura/ecchymosis +50 if positive
Ascites/pleural effusion +150 if positive
PLT −7 for every 10,000 platelets
Pulse pressure −4 for every 1 mmHg
aPLT, platelet. bDerived from the following equation: y = 0.8385 − (day of
admission × 0.4379) + (purpura/ecchymosis × 0.5207) + (ascites/pleural
effusion × 1.4976) − (PLT × 0.0069) − (pulse pressure × 0.0401).
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signs of dengue infection [2]. A short duration of fever
prior to admission was associated with recurrent shock,
suggesting rapid progression of the disease in recurrent
shock patients. The mechanism of this phenomenon is
unknown, thus further studies are required to clarify it.
Several other data-mining techniques, such as ANN,
kNN, J48, LgBoost, LRT, NaiveB, RF, RSSpace, SMO and
Vote, recently have been developed and used to help the
clinician make decisions [37-42]. Though the traditional
Logistic model has been used extensively to develop de-
cision rules, other modern techniques are underutilized
in clinical practices. It has been proposed that intensive
computer-based data-mining classifiers outperform the
traditional classification methods in several data sets
[43-47]. However, this superiority has not been obvious
in other data sets [48,49]. Thus, it is important to com-
pare several models in order to find an optimal clinical
decision-making model for a particular prediction [50].Figure 2 Receiver operating characteristic curves of two
traditional logistic prediction rules for prediction of recurrent
shock during a patient’s first dengue shock episode. The areas
under the receiver operating characteristic curves were 0.733 for the
equation rule and 0.731 for the scoring rule.In our present study, we simultaneously developed, tested
and compared the traditional Logistic model with ten
common prediction models for critical care in dengue
infection. Our results show that all 11 models had signifi-
cant power to predict, around the time of first dengue
shock episode, which patients would develop a second
shock episode. Five models (Vote, LgBoost, NaiveB, Logistic
and LRT) had AUCs >0.7, which is considered an accept-
able discrimination level [51]. Among these five models, no
prediction rule had superior overall accuracy compared to
the other rules. Furthermore, no prediction models were
significantly better than the relatively simple logistic regres-
sion model in terms of overall accuracy (AUC).
There are several limitations of this study. First, we an-
alyzed data from only two hospitals in southern
Vietnam. Therefore, the results would have been differ-
ent if we had used data from other hospitals, particularly
those in other countries, where the clinical characteris-
tics, epidemiology and outcomes of dengue infection are
different. Second, the overall accuracy of the final model
was not so high, thus more markers are needed to im-
prove the efficacy of the rule in future. Third, we did not
include treatment variables at the time of first dengue
shock episode (such as initial fluids and length of stay in
the ICU), Pediatric Risk of Mortality or Sequential
Organ Failure Assessment score variables (such as heart
rate, respiratory rate and creatinine level), which might
have improved the accuracy of the prediction rule. In
addition, we used only one software package to build all
prediction models. Other software could produce differ-
ent results regarding the best model. Thus, further pro-
spective studies using data from different regions are
required for external validation of the results of this study.
Conclusions
Recurrent shock occurs in about 28% of dengue-infected
patients with shock. We derived a simple clinical deci-
sion rule with a sensitivity and specificity of 68%, which
could help clinicians treating dengue patients during the
early stage of a first shock episode to predict the devel-
opment of recurrent shock. The usefulness of this deci-
sion rule needs to be validated by several independent
studies in the future.
Key messages
 Several prediction models were capable of predicting
reshock in children who had a first dengue shock
(AUC >0.7).
 The simple traditional logistic regression model
derived from five factors (admission day, purpura/
ecchymosis, ascites/pleural effusion, blood platelet
count and pulse pressure) provided relatively good
accuracy with an AUC of 0.73.
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Additional file 1: Parameters of the Weka software were optimized
to obtain the highest area under the curve value for each model.
Additional file 2: Head-to-head comparisons of area under the
receiver operating characteristic curves of different models for
predicting recurrent shock during a patient’s first dengue shock
episode.
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